Skip to Main Content
  • Yale Urology
    Yale Physicians Building
    800 Howard Avenue, Ste 3rd Floor
    New Haven, CT 06519
  • Yale Urology
    Orchard Medical Center
    330 Orchard Street, Ste Suite 164
    New Haven, CT 06511
  • Yale Urology
    Greenwich Hospital
    55 Holly Hill Lane, Ste Suite 240
    Greenwich, CT 06830

Isaac Y. Kim, MD, PhD, MBA

Urology, Urologic Oncology
Telehealth is available
Learn more about telehealth
Patient type treated
Child, Adult
Accepting new patients
No
Referral required
Not Applicable
Board Certified in
Urology

Biography

Isaac Yi Kim, MD, PhD, MBA, chair of the Department of Urology at Yale School of Medicine, specializes in the treatment and management of prostate cancer with the goal of helping patients navigate and better understand their disease. Although he cares for all men with localized disease, his clinical and research focus is in men with high-risk disease, recurrence after radiation, and metastatic prostate cancer to lymph nodes, bones, lungs, and abdominal organs.

Dr. Kim is an expert in minimally invasive robotic surgery and has performed more than 2,100 robot-assisted radical prostatectomies, which are surgeries to remove the entire prostate gland. In addition, he has established a same-day radical prostatectomy program by using the latest-generation da Vinci robot to remove a diseased prostate through a single, one-inch incision in the abdomen. This results in less pain—and pain medication—for the patient, who usually goes home the same day of the surgery.

He was inspired to become a prostate surgeon during his medical training, when he decided he wanted to help men he saw struggling with complications such as impotence and incontinence, which often develop after prostate cancer surgery. Those post-surgery problems are less common with expert robotic surgeons, he says. “I see what an impact and a difference the surgical robot has made in helping our patients and allaying their fears.”

As a professor at Yale School of Medicine, Dr. Kim is also a surgeon-scientist who is studying the mechanism of prostate cancer treatment resistance. He is the principal investigator in clinical trials focused on advanced and metastatic prostate cancer, providing surgery in men with Stage IV prostate cancer. He says the traditional paradigm shows that when cancer cells have escaped the organ of origin, it’s too late to help. But his early data is showing that removing the prostate may enhance the effectiveness of chemotherapy and hormonal therapies for men with late-stage disease.

Dr. Kim says working at Yale Medicine is rewarding because of the rich history and tradition that values innovation and creativity, and he is focused on providing the latest treatments for men who have any stage of prostate cancer. “Yale Urology is one of the larger departments in the nation and we attract patients from regions far beyond New Haven. We’re really dedicated to delivering the most innovative care in the most compassionate manner,” he says. “When a patient and concerned family members come in with a prostate cancer diagnosis, and I’m able to take care of it and see how he recovers, it is truly a privilege and a blessing.”

Titles

  • Professor, Urology
  • Chair, Urology
  • Chief, Urology

Education & Training

  • MBA
    University of Pennsylvania Wharton Business School, Finance (2017)
  • Research Fellowship
    National Institutes of Health (2005)
  • Clinical Fellowship
    University of California, Irvine (2005)
  • Resident
    Baylor College of Medicine (2003)
  • MD
    Northwestern University, Feinberg School of Medicine (1997)
  • PhD
    Northwestern University Graduate School, Tumor Cell Biology (1996)

Additional Information

Biography

Isaac Yi Kim, MD, PhD, MBA, chair of the Department of Urology at Yale School of Medicine, specializes in the treatment and management of prostate cancer with the goal of helping patients navigate and better understand their disease. Although he cares for all men with localized disease, his clinical and research focus is in men with high-risk disease, recurrence after radiation, and metastatic prostate cancer to lymph nodes, bones, lungs, and abdominal organs.

Dr. Kim is an expert in minimally invasive robotic surgery and has performed more than 2,100 robot-assisted radical prostatectomies, which are surgeries to remove the entire prostate gland. In addition, he has established a same-day radical prostatectomy program by using the latest-generation da Vinci robot to remove a diseased prostate through a single, one-inch incision in the abdomen. This results in less pain—and pain medication—for the patient, who usually goes home the same day of the surgery.

He was inspired to become a prostate surgeon during his medical training, when he decided he wanted to help men he saw struggling with complications such as impotence and incontinence, which often develop after prostate cancer surgery. Those post-surgery problems are less common with expert robotic surgeons, he says. “I see what an impact and a difference the surgical robot has made in helping our patients and allaying their fears.”

As a professor at Yale School of Medicine, Dr. Kim is also a surgeon-scientist who is studying the mechanism of prostate cancer treatment resistance. He is the principal investigator in clinical trials focused on advanced and metastatic prostate cancer, providing surgery in men with Stage IV prostate cancer. He says the traditional paradigm shows that when cancer cells have escaped the organ of origin, it’s too late to help. But his early data is showing that removing the prostate may enhance the effectiveness of chemotherapy and hormonal therapies for men with late-stage disease.

Dr. Kim says working at Yale Medicine is rewarding because of the rich history and tradition that values innovation and creativity, and he is focused on providing the latest treatments for men who have any stage of prostate cancer. “Yale Urology is one of the larger departments in the nation and we attract patients from regions far beyond New Haven. We’re really dedicated to delivering the most innovative care in the most compassionate manner,” he says. “When a patient and concerned family members come in with a prostate cancer diagnosis, and I’m able to take care of it and see how he recovers, it is truly a privilege and a blessing.”

Titles

  • Professor, Urology
  • Chair, Urology
  • Chief, Urology

Education & Training

  • MBA
    University of Pennsylvania Wharton Business School, Finance (2017)
  • Research Fellowship
    National Institutes of Health (2005)
  • Clinical Fellowship
    University of California, Irvine (2005)
  • Resident
    Baylor College of Medicine (2003)
  • MD
    Northwestern University, Feinberg School of Medicine (1997)
  • PhD
    Northwestern University Graduate School, Tumor Cell Biology (1996)

Additional Information

  • Yale Urology
    Yale Physicians Building
    800 Howard Avenue, Ste 3rd Floor
    New Haven, CT 06519
  • Yale Urology
    Orchard Medical Center
    330 Orchard Street, Ste Suite 164
    New Haven, CT 06511
  • Yale Urology
    Greenwich Hospital
    55 Holly Hill Lane, Ste Suite 240
    Greenwich, CT 06830